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5(IV) by 7%. In contrast to their opposing actions on 1 andEffects of high glucose and TGF-1 on the expression of colla-
5(IV), both HG and exogenous TGF-1 increased 3(IV)gen IV and vascular endothelial growth factor in mouse podo-
collagen and VEGF, with TGF-1 having the greater effect.cytes.
An inhibitor of the TGF- type I receptor (ALK5) was ableBackground. The podocyte takes center stage in the patho-
to prevent the stimulation of 3(IV) and VEGF proteins bygenesis of glomerular basement membrane (GBM) thickening
HG. Unlike in other renal cell types, HG did not increaseand proteinuria in diabetic glomerulopathy. In part, GBM
TGF-1 mRNA or protein in the podocyte, but HG did inducethickening may occur when the podocyte synthesizes increased
the expression of the ligand-binding TGF- type II receptoramounts of collagen IV. Proteinuria may develop if the podo-
(TRII). Because HG had up-regulated TRII after two weeks,cyte secretes excessive amounts of vascular endothelial growth
the addition of physiological-dose TGF-1 (0.010 ng/mL) for 24factor (VEGF), which may increase the glomerular permeabil-
ity to macromolecules. The augmented production of collagen hours stimulated the production of 3(IV) and VEGF proteins
IV and VEGF may be caused by metabolic mediators of diabe- to a greater extent in high than in normal glucose. Up-regula-
tes such as hyperglycemia and transforming growth factor- tion of TRII in the podocyte was corroborated by immunohis-
(TGF-). tochemistry of the kidney cortex in the db/db mouse, a model
Methods. The effects of high glucose and exogenous TGF-1 of type 2 diabetes.
were examined on a mouse podocyte cell line that retains Conclusions. High glucose and exogenous TGF-1 exert dis-
its differentiated phenotype. The gene expression and protein parate effects on the expression of 1 and 5(IV) collagen.
production of certain alpha chains of collagen IV, the major However, high glucose and TGF-1 coordinately induce the
isoforms of VEGF, and components of the TGF- system were production of 3(IV) collagen and VEGF in the podocyte.
assayed. An inhibitor of TGF- signaling was used to determine The HG-induced increases in 3(IV) collagen and VEGF pro-
whether some of the high glucose effects might be mediated teins are mediated by the TGF- system. By increasing the
by the TGF- system. expression of TRII, high glucose may augment the response
Results. Compared with normal glucose (5.5 mmol/L), high of the podocyte to ambient levels of TGF-1.
glucose (HG, 25 mmol/L) for 14 days stimulated [3H]-proline
incorporation, a measure of collagen production, by 1.8-fold,
and exogenous TGF-1 (2 ng/mL) for 24 hours stimulated
Diabetic nephropathy involves structural alterationsproline incorporation by 2.4-fold. Northern analysis showed
that exposure to HG for 14 days increased the mRNA level that are characterized by early hypertrophy of glomeru-
of 1(IV) collagen by 51% and 5(IV) by 90%, whereas treat- lar and tubular components, the subsequent develop-
ment with TGF-1 (2 ng/mL) for 24 hours decreased the
ment of thickened glomerular and tubular basementmRNA level of 1(IV) by 36% and 5(IV) by 40%. Consistent
membranes, and the progressive accumulation of extra-with these effects on mRNA expression, Western blotting
showed that HG increased 1(IV) protein by 44% and 5(IV) cellular matrix proteins in the glomerular mesangium
by 28%, while TGF-1 decreased 1(IV) protein by 29% and and tubulointerstitium. Functionally, the alterations in
the diabetic kidney include the early development of
glomerular hyperfiltration, the increased urinary excre-Key words: diabetic nephropathy, glomerular basement membrane,
epithelial cell, proteinuria, hypertrophy, foot process. tion of albumin, and the subsequent development of
renal insufficiency [1].Received for publication July 18, 2001
Three layers constitute the glomerular filtration bar-and in revised form February 21, 2002
Accepted for publication April 22, 2002 rier: the fenestrated vascular endothelial cells, the glo-
merular basement membrane (GBM), and the visceral 2002 by the International Society of Nephrology
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epithelial cells or podocytes. The podocyte is a highly induced diabetic rats [32]. Neutralizing the excess VEGF
activity with an anti-VEGF antibody largely preventsdifferentiated cell type that synthesizes components of
the GBM, such as type IV collagen [2], and forms an the development of albuminuria in STZ-diabetic rats
[33]. Because glomerular VEGF expression is strongestinterdigitating network of foot processes, which are
spanned by slit diaphragms. The GBM and the slit dia- in the podocyte [34, 35], investigators have theorized
that an increased production of VEGF by the podocytephragm make up the bulk of the glomerular filtration
barrier [3]. The GBM in the adult mammal is composed may promote the development of proteinuria in diabetic
nephropathy.of two different networks of type IV collagen. The ubiq-
uitous 1(IV) and 2(IV) chains are found in virtually Studying the in vitro podocyte in its differentiated
state is desirable, but achieving this has been trouble-all basement membranes and are present in the subendo-
thelial aspect of the GBM. On the other hand, the novel some because standard cell culture methods induce cellu-
lar proliferation but provoke the loss of differentiation3(IV), 4(IV), and 5(IV) chains are much more re-
stricted in their tissue distribution and are present [36]. However, with the recent establishment of a mouse
podocyte cell line that is conditionally immortalized, thethroughout the width of the glomerular and alveolar
basement membranes [4, 5]. study of fully differentiated podocytes in culture has
become feasible [37]. These cells divide under one setAlterations in the morphology of the podocyte, from
the disruption of foot process architecture to the loss of of culture conditions (that is, permissive) but then differ-
entiate under another set of conditions (that is, non-entire podocytes, are associated with significant protein-
uria in many glomerular diseases [3, 6, 7]. In diabetic permissive). Thus, by manipulating the cell culture envi-
ronment, the investigator can propagate podocytes tonephropathy, the podocyte number is markedly reduced
(with associated podocyturia), the foot process width is maintain the cell line or induce them to differentiate for
the purposes of experimentation [37].significantly widened, and the slit diaphragm becomes
narrower as the glomerular filtration rate declines [7–11]. Our current study investigates the effects of high glu-
cose and TGF-1 on the cultured differentiated podocyteSeveral pieces of evidence link the effects of hypergly-
cemia to activation of the intrarenal transforming growth [37] with respect to the expression of type IV collagen
and VEGF because these proteins are likely involved infactor- (TGF-) system [12]. We and others have shown
that TGF-1 mRNA and protein are elevated in the the pathogenesis of GBM thickening and proteinuria.
We also examine whether high glucose modulates thekidneys of diabetic animals [13–16]. The ligand-binding
TGF- type II receptor (TRII) is up-regulated in the expression of components of the TGF- system in podo-
cytes, both in vitro and in vivo. Finally, an inhibitor ofdiabetic kidney as well [17, 18]. Hyperglycemia appears
to be a cause of the increased TGF-1 and TRII in the kinase activity of TGF- type I receptor (ALK5
inhibitor), SB-431542 [38], was used to ascertain whetherthe kidney because high glucose media reproduce these
changes in cultured renal cells [17, 19–22]. Furthermore, some of the high glucose effects on podocytes may be
mediated by the TGF- system.the hypertrophic and profibrotic effects of high glucose
are duplicated by treatment with TGF-1 alone [12].
Finally, neutralization of TGF- activity in cell culture
METHODS
and in diabetic animals prevented cellular and renal hy-
Cell culturepertrophy, overexpression of extracellular matrix pro-
teins, and diabetic glomerulosclerosis, proving that the All media and reagents used for cell culture were pur-
chased from Gibco BRL (Gaithersburg, MD, USA). Cul-TGF- system mediates many of the nephropathic ef-
fects of high glucose and diabetes [16, 23, 24]. tivation of mouse podocytes that were conditionally im-
mortalized with a temperature-sensitive variant of theVascular endothelial growth factor (VEGF) stimulates
new blood vessel formation (angiogenesis) and dramati- SV40 large T antigen (tsA58) was performed as de-
scribed [37]. Briefly, podocytes were maintained incally increases the permeability of the microvasculature
to plasma proteins, hence its original name vascular per- RPMI 1640 that was supplemented with 10% fetal calf
serum (FCS), 100 U/mL penicillin, and 100 g/mL strep-meability factor (VPF) [25–28]. In diabetes, VEGF plays
a major role in the neovascularization of proliferative tomycin. To propagate podocytes, cells were cultivated
at 33C and treated with 10 U/mL of mouse recombinantretinopathy [29] and in the breakdown of the blood-
retinal barrier, characterized by hyperpermeability of -interferon (permissive conditions) to enhance expres-
sion of the large T antigen [39]. To induce differentiation,the retinal vessels [30]. In as much as retinopathy and
nephropathy are both microvascular complications of podocytes were maintained on a bed of type I collagen
at 37C and deprived of -interferon (non-permissivediabetes, VEGF also may enhance the permeability of
the glomeruli to macromolecules, leading to albuminuria conditions) for 14 days in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 5% FCS, penicil-[31]. The expression of VEGF and its receptor is signifi-
cantly increased in the kidneys of streptozotocin (STZ)- lin, and streptomycin.
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Experimental design Isolation of membrane proteins for TRII
During the differentiation period, podocytes in culture Podocytes were washed twice with ice-cold PBS and
were exposed to DMEM with 5% FCS containing either then collected by scraping in a detergent-free lysis buffer
a normal d-glucose concentration (5.5 mmol/L) or a high [50 mmol/L Tris (pH 8.0), 150 mmol/L NaCl, 1 mmol/L
d-glucose concentration (25 mmol/L) for 14 days. At ethylenediaminetetraacetic acid (EDTA), 0.5 mmol/L
day 7, the culture media were changed to fresh normal dithiothreitol (DTT)] with protease inhibitor cocktail
glucose or high glucose media. In some experiments, a (Sigma, St. Louis, MO, USA). The cells were passed
third group of podocytes was exposed to 5.5 mmol/L through a 23-gauge needle 30 times for mechanical dis-
d-glucose plus 19.5 mmol/L d-mannitol to control for ruption. After centrifugation at 1000 g for five minutes
the osmotic effects of high glucose. Exogenous TGF-1 at 4C, the supernatant was collected and subjected to
(R&D Systems, Minneapolis, MN, USA), ranging from ultracentrifugation at 100,000  g for 30 minutes at 4C.
0.010 to 2.0 ng/mL, was added for the last 24 hours of The supernatant was discarded and the pellet, containing
the 14-day incubation as indicated. In the experiments the membrane fraction, was dissolved in lysis buffer with
that block the TGF- signaling pathway, 1 mol/L of detergent [above plus 0.1% sodium dodecyl sulfate
an ALK5 inhibitor, SB-431542 (gift of Dr. N. Laping; (SDS) and 1% NP-40] to release the proteins from the
GlaxoSmithKline, King of Prussia, PA, USA), was added membrane lipid bilayer. After a final centrifugation at
for the last 7 days of the 14-day incubation. Total RNA 10,000  g for 15 minutes at 4C, the supernatant, con-
or cell lysate protein or cell culture supernatants were taining the membrane proteins, was processed for West-
then harvested. ern blotting.
Measurement of [3H]-proline incorporation Immunoblot (Western) analysis
To study the kinetics of high glucose-induced collagen Cell lysates were prepared in Laemmli sample buffer
production in podocytes, we studied [3H]-proline incor- and boiled for five minutes. Aliquots of cellular protein
poration into proteins. Podocytes were seeded onto 24- (20 to 25g) were subjected to SDS-10% polyacrylamide
well plates (Nunclon, Roskide, Denmark) and exposed gel electrophoresis (PAGE) and then transferred to a
to normal or high glucose for up to 14 days. Exogenous nitrocellulose membrane (Micron Separations Inc., West-
TGF-1 (2 ng/mL) was added for the last 24 hours of borough, MA, USA). The membrane was blocked with
the incubation. In the last 16 hours, the cells were pulsed 5% nonfat milk in Tris buffered saline-0.1% Tween-20
with 1 Ci of L-[2,3,4,5-3H] proline (Amersham Phar- at room temperature for one hour and then probed with
macia, Piscataway, NJ, USA). Radiolabeled podocytes rabbit anti-1(IV) collagen [43], human anti-3(IV) col-
were washed twice in ice-cold phosphate-buffered saline lagen (gift of Dr. M. Madaio, Philadelphia, PA, USA)
(PBS) and then dissolved in 0.5 N NaOH with 0.1% [44], rabbit anti-5(IV) collagen [43], mouse anti-VEGF
Triton X-100. After neutralization with 0.5 N HCl, the (NeoMarkers, Fremont, CA, USA), or rabbit anti-TRII
incorporated radioactivity was measured in a liquid scin- (Santa Cruz Biotechnology, Santa Cruz, CA, USA) anti-
tillation counter. Proline incorporation was corrected for
body at 4C for 16 hours. After several washes, a horse-
the cellular protein content.
radish peroxidase (HRP)-conjugated secondary antibody
was used to detect the immunoreactive bands with anNorthern analysis
enhanced chemiluminescence system, ECL Plus (Amer-Murine 1(IV), TGF-1, and TRII cDNA probes
sham Pharmacia).were synthesized by reverse transcription-polymerase
chain reaction of mouse kidney RNA and cloned into Enzyme-linked immunosorbent assay
the pCRII TA cloning vector (Invitrogen, La Jolla, CA,
Supernatants from each cell culture condition wereUSA) as described previously [16]. An 800-bp BamHI-
frozen at 20C until assayed by a TGF-1 or VEGFHindIII fragment encoding 3(IV) and an 800-bp cDNA
enzyme-linked immunosorbent assay (ELISA) kit, per-for 5(IV) were used [40, 41]. The cDNA probe for
formed according to the manufacturer’s instructionsVEGF recognizes the 523- to 973-bp portion of the
(R&D Systems). In brief, for the TGF-1 ELISA, themouse VEGF transcript, which is common to the major
supernatants of the podocyte cultures were acid-acti-VEGF isoforms, and was purchased from American
vated with 1 N HCl followed by neutralization with 1.2Type Culture Collection (ATCC, Manassas, VA, USA).
N NaOH/0.5 mol/L HEPES to measure total TGF-1Total RNA was isolated using TRIzol reagent (Gibco
(latent plus active) or left untreated with acid to measureBRL). Northern blot and hybridization were performed
active TGF-1 only. Samples were applied to microtiteras previously described [42]. Exposed films and stained
plates that had been pre-coated with the TGF- type IImembranes were scanned and analyzed with the NIH
receptor. After an incubation of three hours at roomImage 1.62c program, and mRNA levels relative to 28S
rRNA were calculated. temperature, the wells were washed and horseradish per-
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oxidase (HRP)-conjugated anti-TGF-1 antibody was
added to the wells for 1.5 hours at room temperature.
After another wash, a solution containing substrate for
HRP was added. The resulting chromogenic reaction
was halted with a stop solution. The absorbance at 450
nm was measured in a microplate reader. TGF-1 con-
centrations were determined from the standard curve
and corrected for the amount of total cell protein.
For the VEGF ELISA, the cell culture supernatants
were dispensed onto a microtiter plate coated with an
anti-VEGF antibody that recognizes mouse VEGF120, 164.
Fig. 1. High glucose and exogenous transforming growth factor 1After a two hour incubation, a secondary anti-VEGF (TGF-1) increase proline incorporation in cultured differentiated
antibody, conjugated to HRP, was added for an addi- mouse podocytes. Podocytes were seeded onto 24-well plates and then
exposed to normal glucose (NG), high glucose (HG), or mannitoltional two hours. The chromogenic reaction was devel-
(NGMAN) for 14 days; or exposed to 2 ng/mL of TGF-1 (NGT)oped with the substrate solution as above. After addition
for 24 hours. In the last 16 hours, the podocytes were pulsed with 1 Ciof a stop solution, the absorbance at 450 nm was mea- of L-[2,3,4,5-3H] proline (Amersham Pharmacia). The amount of [3H]-
sured. The total amount of secreted VEGF was extrapo- proline incorporation, measured in a scintillation counter, was corrected
for the cellular protein content. The results are expressed as percentageslated from the standard curve and then corrected for the
of the control (NG) and are the mean 	 SEM of three independentamount of total cell protein.
experiments. *P 
 0.05 vs. NG.
In vivo studies
Diabetic db/db and non-diabetic db/m mice were pur-
chased from Jackson Laboratory (Bar Harbor, ME, USA) mate of collagen production. We first examined whether
and killed at 16 weeks of age when the db/db mice had high glucose or exogenous TGF-1 stimulates collagen
been frankly hyperglycemic for approximately eight production. Exposure to high glucose for the last 24 to
weeks and had developed lesions of diabetic nephropa- 96 hours of the incubation period did not change the
thy [24]. The left kidney was excised, bisected, and pro- proline incorporation (data not shown). However, expo-
cessed in fixative solutions. The immunohistochemical sure to high glucose for 14 days significantly stimulatedstaining for TGF-1 and TRII was performed as pre-
proline incorporation by 84% (P 
 0.05, N  3, Fig. 1).viously described [18]. Kidney sections were incubated
The stimulatory effect of high glucose was not due to itsovernight at 4C with one of two primary antibodies at
osmolarity since the addition of d-mannitol to raise thea 1:100 dilution: a polyclonal rabbit antibody against
total sugar concentration to 25 mmol/L did not stimulatemouse TGF-1 or a polyclonal rabbit antibody against
proline incorporation (NGMAN, 84 	 11% of normalmouse TRII (both from Santa Cruz Biotechnology).
glucose, N  3; Fig. 1). Similar to high glucose, TGF-1The same concentration of an isotype-matched antibody
significantly increased proline incorporation into podo-of irrelevant specificity was used as a negative control.
After three five-minute washes in phosphate-buffered cytes by more than twofold (NGT, 242 	 39% of nor-
saline (PBS), a biotinylated anti-rabbit antibody and then mal glucose, P 
 0.05, N  3; Fig. 1).
HRP-conjugated streptavidin (Vector Laboratories, Bur-
Effects of high glucose and exogenous TGF-1lingame, CA, USA) were applied to the kidney sections
on the expression of collagen IV chainsfor 45 minutes. The color reaction was developed with
the diaminobenzidine detection kit (Vector Labora- Having found that both high glucose and TGF-1 stim-
tories), and the sections were counterstained with hema- ulate collagen production, we focused on collagen IV,
toxylin. the predominant type of collagen in the GBM. Specifi-
cally, the gene expression and protein production of threeStatistical analysis
of the alpha chains of collagen IV were examined in re-Results are shown as the mean 	 SEM, and N repre-
sponse to high glucose and exogenous TGF-1. The 1,sents the number of experiments. In each case, the paired
3, and 5 chains were studied because each is half ofStudent t test was used to compare the control with the
a pair of genes that encode the six alpha chains of colla-experimental group. P
 0.05 was considered statistically
gen IV. In the mouse, the genes for 1 and 2 are pairedsignificant.
head-to-head on chromosome 8 [45], those for 3 and
4 are head-to-head on chromosome 1 [46], and those
RESULTS for 5 and 6 are head-to-head on chromosome X [47].
High glucose and exogenous TGF-1 increase The relative changes in the mRNA expression and
proline incorporation protein levels of the 1 and 5 chains of collagen IV
were examined first under normal versus high glucoseBecause collagen is rich in proline, the incorporation
of radiolabeled proline into cells serves as a rough esti- conditions. By Northern analysis of podocytes under nor-
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Fig. 2. High glucose increases the expression
of1 and5(IV) collagen in podocytes. Podo-
cytes were incubated for 14 days in normal
glucose (NG) or high glucose (HG), and total
RNA or cell lysate protein was harvested as
described in the Methods. The gene expres-
sion and protein production of the 1 and
5 chains of collagen IV were analyzed by
Northern blotting and Western blotting, re-
spectively. The densitometric ratios of the 1
and 5(IV) mRNA bands to 28S rRNA (A),
and the densitometric values of the 1 and
5(IV) protein bands (B) are shown as per-
centages of the control (NG). Results are ex-
pressed as the mean 	 SEM of five indepen-
dent experiments. *P 
 0.05 vs. NG.
mal glucose, the 1 and 5 chains were constitutively normal glucose, P 
 0.05, N  9; Fig. 4B). Perhaps high
glucose causes 3(IV) collagen to accumulate by a post-expressed. Exposing the podocyte to high glucose for 14
days significantly increased the mRNA levels of both transcriptional mechanism without affecting its tran-
script levels in the steady-state. Even more striking thanthe 1 and 5(IV) chains (151 	 24% and 190 	 21%
of normal glucose, respectively, P
 0.05, N 5; Fig 2A). high glucose, exogenous TGF-1 elevated the level of
3(IV) protein by 3.3-fold (P 
 0.05, N  5; Fig. 4C).By Western blotting, high glucose significantly increased
the protein production of the 1 and 5(IV) chains as
Effects of high glucose and exogenous TGF-1well (144	 7% and 128	 4% of normal glucose, respec-
on the expression of VEGFtively, P 
 0.05, N  5; Fig. 2B), consistent with the
changes in mRNA expression. Compared with incubation in normal glucose, expo-
sure to high glucose for 14 days significantly increasedWe next focused on the effects of exogenous TGF-1
on 1 and 5(IV) collagen. Treatment with 2 ng/mL of the level of VEGF transcripts in differentiated podocytes
by 70% (P
 0.05, N 5; Fig. 5A). Likewise, by Westernexogenous TGF-1 for 24 hours significantly inhibited
the gene expression of the 1 chain by 36% and that of blotting on whole cell lysate, high glucose raised the
protein production of VEGF by 75% (P 
 0.05, N  4;the 5 chain by 41% (P
 0.05, N 4; Fig. 3A), contrary
to the stimulatory effects of high glucose (Fig. 2A). West- Fig. 5B). The particular VEGF isoform that was in-
creased could not be determined, because the primaryern blotting showed that TGF-1 also decreased the
amount of 1(IV) protein by 29% (P 
 0.05, N  4; antibody used in Western blotting recognizes all three
of the major isoforms (VEGF120, 164, 188). An ELISA forFig. 3B) but had little inhibitory effect on the quantity
of 5(IV) protein (P  NS, N  8; Fig. 3B). VEGF120, 164 (R&D Systems), however, revealed that cell
culture supernatants are not enriched in these secretedFinally, the effects of high glucose and TGF-1 on the
gene expression and protein levels of 3(IV) collagen isoforms of VEGF under high glucose conditions (Fig.
5C). This suggests that the increase in VEGF by highwere studied. By Northern analysis, the bands represent-
ing the mRNA expression of 3(IV) were weak under glucose is due to a rise in VEGF188, which is contained
in the cell lysate but not secreted into the supernatant.normal glucose and high glucose. However, TGF-1
treatment made the band easily visible (Fig. 4A). It The addition of 2 ng/mL of TGF-1 for 24 hours sig-
nificantly elevated the mRNA expression of VEGF inseems that podocytes under basal or high glucose condi-
tions do not express perceivable bands of 3(IV) mRNA differentiated podocytes by 2.5-fold (P 
 0.05, N  5,
Fig. 6A). This stimulation was both time- and dose-by Northern analysis. Nevertheless, the 3(IV) cDNA
probe functions well and is probably detecting authentic dependent, becoming evident in as little as two hours
and at a dose as low as 0.010 ng/mL (data not shown). Thelevels of 3(IV) gene expression since the TGF-1–
induced 3(IV) band is quite evident (Fig. 4A). Interest- increase in VEGF mRNA due to exogenous TGF-1
correlated with an increase in the protein productioningly, high glucose was still able to increase the amount
of 3(IV) protein by Western blotting (143 	 5% of of VEGF, measured by Western blotting of cell lysate
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Fig. 3. Effects of exogenous TGF-1 on the
expression of1 and 5(IV) collagen in podo-
cytes. After incubation in normal glucose for
14 days, podocytes were treated with or with-
out 2 ng/mL of TGF-1 for 24 hours. The gene
expression and protein production of the 1
and 5 chains of collagen IV were analyzed
by Northern blotting and Western blotting,
respectively. The densitometric ratios of the
1 and 5(IV) mRNA bands to 28S rRNA
(A), and the densitometric values of the 1
and 5(IV) protein bands (B) are shown as
percentages of the control (NG). Results are
expressed as the mean	 SEM of four to eight
independent experiments. *P 
 0.05 vs. Con-
trol.
Fig. 4. Both high glucose and exogenous
TGF-1 increase levels of 3(IV) collagen.
Podocytes were exposed to high glucose or
treated with 2 ng/mL of exogenous TGF-1,
as previously described. Representative bands
of 3(IV) collagen mRNA are shown (A).
Note that the percentage increase in mRNA
expression due to high glucose or TGF-1
could not be quantified, because the control
3(IV) band was not detectable above back-
ground. By Western blotting, the protein pro-
duction of 3(IV) collagen is shown under
high glucose conditions (B) or with TGF-1
treatment (C ). The densitometric values of
the 3(IV) protein bands are expressed as
percentages of the control (NG in both cases).
Results are the mean	 SEM of nine (panel B)
or five (panel C) independent experiments.
*P 
 0.05 vs. NG or Control.
(TGF-1, 227	 44% of control, P
 0.05, N 4; Fig. 6B) these high glucose effects are possibly mediated by the
TGF- system. The TGF- ligand ultimately signalsand ELISA (R&D Systems) of cell culture supernatant
(TGF-1, 216 	 4% of control, P 
 0.05, N  4; Fig. through the TGF- type I receptor or activin-like kinase
(ALK5), which phosphorylates the Smad proteins that6C). The data suggest that, unlike high glucose, TGF-1
stimulates the production of secreted VEGF isoforms carry the TGF- signal to the nucleus [48]. Therefore,
an ALK5 inhibitor (SB-431542) was used to determine(VEGF120, 164). However, a stimulatory effect of TGF-1
on VEGF188 cannot be ruled out. whether the effect of high glucose would be prevented by
TGF- blockade. We found that the increase in 3(IV)
Certain high glucose effects mediated protein secondary to high glucose was completely pre-
by the TGF- system vented by SB-431542 (HG: 136 	 3% of normal glucose
vs. HGSB-431542, 77 	 8%, P 
 0.05, N  6; Fig.Because high glucose and exogenous TGF-1 both
stimulate the expression of 3(IV) collagen and VEGF, 7A). The high glucose-induced increase in VEGF protein
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Fig. 5. Effects of high glucose on mRNA ex-
pression and protein production of VEGF.
Podocytes were incubated for 14 days in normal
glucose (NG) or high glucose (HG). Northern
analysis using a cDNA probe for VEGF (A),
Western blotting with an anti-VEGF antibody
(B), and ELISA for VEGF120, 164 on cell cul-
ture supernatants (C ) were performed as de-
scribed. Representative Northern and West-
ern bands of VEGF mRNA and protein,
respectively, are shown. Results are expressed
as percentages of the control (NG) and are
the mean 	 SEM of five (panel A) or four
(panels B and C) independent experiments.
*P 
 0.05 vs. NG.
Fig. 6. Exogenous TGF-1 increases mRNA
expression and protein production of VEGF.
Podocytes were incubated in normal glucose
for 14 days and then treated with or without 2
ng/mL of exogenous TGF-1 (T) for 24 hours.
Northern analysis for VEGF mRNA (A) and
Western blotting for VEGF protein (B) were
performed as described. ELISA for mouse
VEGF120, 164 was performed on cell culture su-
pernatants (C ). The quantity of VEGF (pg)
was corrected for the total protein content
(mg), and the results are expressed as percent-
ages of the control (normal glucose). Results
are shown as the mean	 SEM of five (panel A)
or four (panels B and C) independent experi-
ments. *P 
 0.05 vs. Control.
was partially prevented by SB-431542 (HG, 145 	 14% Effects of high glucose and exogenous TGF-1
on the expression of TGF-1 and TRIIof normal glucose vs. HGSB-431542, 109 	 14%, P 

0.05, N  7; Fig. 7B). Of note, the ALK5 inhibitor was Since high glucose stimulates the production of
probably not toxic to the podocyte, since the individual TGF-1 in almost all renal cell types [19–21, 23], we
and total protein levels were not significantly different investigated whether high glucose would stimulate the
mRNA expression and protein production of TGF-1from normal glucose to normal glucoseSB-431542.
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Fig. 7. Inhibition of TGF- type I receptor
(ALK5) prevents high glucose-induced changes
in 3(IV) collagen and VEGF. Podocytes were
incubated in normal glucose (NG) or high glu-
cose (HG) for 14 days. In the last 7 days, cells
were treated with or without an ALK5 inhibi-
tor, SB-431542, at a concentration of 1 mol/L.
The protein production of 3(IV) collagen
(A) and VEGF (B) was analyzed by Western
blotting. Representative groups of 3(IV) col-
lagen and VEGF bands, each from a single ex-
periment, are shown. The densitometric values
of the protein bands are reported as percentages
of the control (NG) and are the mean	SEM of
six (panel A) or seven (panel B) independent
experiments. *P 
 0.05 vs. NG or HG as indi-
cated.
Fig. 8. High glucose does not significantly in-
crease TGF-1 in podocytes. Podocytes were
exposed for 14 days to normal glucose (NG)
or high glucose (HG). (A) TGF-1 mRNA ex-
pression was analyzed by Northern blotting.
The densitometric ratios of the TGF-1 mRNA
bands to 28S rRNA are shown as percentages
of the control (NG). Results are the mean 	
SEM of ten independent experiments. P 
NS vs. NG. (B) Total TGF-1 protein (latent
plus active) in the cell culture supernatant was
assayed by ELISA and performed according
to the manufacturer’s instructions (R&D Sys-
tems). The quantity of TGF-1 protein (pg)
was corrected for the total protein content
(mg). Results are expressed as percentages of
the control (NG) and are the mean 	 SEM of
six independent experiments. P  NS vs. NG.
in the differentiated podocyte. As shown in Figure 8A, The effects of exogenous TGF-1 on the expression
of TGF-1 and TRII were examined next. The additionhigh glucose increased the mRNA level of TGF-1, but
not by a statistically significant amount (HG, 120 	 6% of 2 ng/mL of TGF-1 for 24 hours slightly increased
the expression of TGF-1 mRNA (TGF-1, 118 	 14%of normal glucose, P  NS, N  10). To corroborate
this finding, we measured the production of TGF-1 by of control, P  NS, N  4). Similarly, the mRNA level
of TRII was not significantly altered by exogenousELISA. The amounts of total TGF-1 protein in both
the cell lysate (data not shown) and the cell culture TGF-1 (TGF-1, 97 	 13% of control, P  NS, N  4).
supernatant were not significantly different under high
High glucose increases the effects of ambient TGF-1glucose vs. normal glucose conditions (HG, 110 	 5%
of normal glucose, P  NS, N  6; Fig. 8B). In this set of experiments, the dose of exogenous
Although high glucose did not stimulate TGF-1, it TGF-1 was chosen according to the ambient concentra-
significantly increased the mRNA expression of TRII tion of endogenous TGF-1. The mean concentration
of active TGF-1 in the conditioned media of podocytesby 70% compared with normal glucose (P 
 0.05, N 
6; Fig. 9A). This high glucose effect translated into an after two weeks in normal glucose was 0.014 	 0.004
ng/mL (N  4). Therefore, we added 0.010 ng/mL ofincreased level of TRII protein on the cell surface (HG,
160 	 26% of normal glucose, P 
 0.05, N  4, Fig. 9B), exogenous TGF-1 to nearly double the level of active
TGF-1 in the next 24 hours. Both high glucose andassessed by Western blotting of proteins isolated from
the cell membrane. TGF-1 alone (that is, NGTGF-1) increased the
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Fig. 9. High glucose stimulates expression and
increases cell membrane quantity of TGF-
type II receptor (TRII). Podocytes were ex-
posed for 14 days to normal glucose (NG) or
high glucose (HG). (A) TRII mRNA expres-
sion was analyzed by Northern blotting. The
densitometric ratios of the TRII mRNA
bands to 28S rRNA are shown as percentages
of the control (NG). Results are expressed as
the mean 	 SEM of six independent experi-
ments. *P 
 0.05 vs. NG. (B) The amount of
TRII protein on the podocyte cell surface
was assessed by Western blotting of proteins
isolated from the plasma membranes as de-
scribed. Results are expressed as percentages
of the control (NG) and are the mean	 SEM
of four independent experiments. *P 
 0.05
vs. NG.
Fig. 10. Combined effects of high glucose and
exogenous TGF-1 on protein production of
3(IV) collagen and VEGF. Podocytes were
exposed to normal glucose (NG) or high glu-
cose (HG) for 14 days. In the last 24 hours,
cells were treated with 0.010 ng/mL of exoge-
nous TGF-1, which approximates the physio-
logical concentration of active TGF-1 in podo-
cyte cell culture. The protein production of
3(IV) collagen (A) and VEGF (B) was ana-
lyzed by Western blotting. Representative
groups of 3(IV) collagen and VEGF bands,
each from a single experiment, are shown. The
densitometric values of the protein bands are
reported as percentages of the control (NG)
and are the mean 	 SEM of four independent
experiments. *P
 0.05 vs. NG or NGTGF-1
as indicated.
amounts of 3(IV) collagen (HG, 163 	 14% of normal glomerulus [18]. No appreciable increase in TGF-1 pro-
glucose; TGF-1, 231 	 43% of NG, both P 
 0.05 vs. tein was seen, however, in the podocytes (data not
NG, N  4; Fig. 10A) and VEGF protein (HG, 162 	 shown). On the other hand, immunohistochemistry did
24% of normal glucose; TGF-1, 193 	 35% of NG, reveal an increased amount of the TRII protein in the
both P
 0.05 vs. NG, N  4; Fig. 10B). After two weeks podocytes of diabetic db/db mice (Fig. 11). The in vivo
in high glucose, the podocytes responded to 0.010 ng/mL observations thus agree with our in vitro data, demon-
exogenous TGF-1 by producing more 3(IV) collagen strating that high glucose stimulates the expression of
(HGTGF-1, 269 	 43% of normal glucose, P 
 0.05 TRII but not TGF-1 in the cultured differentiated
vs. NGTGF-1; Fig. 10A) and VEGF (225 	 47% of podocyte.
normal glucose, P 
 0.05 vs. NGTGF-1; Fig. 10B)
than in response to either high glucose or TGF-1 alone.
DISCUSSION
Localization of TGF-1 and TRII in podocytes Our conditionally immortalized cell model allowed the
in vivo study of the podocyte in its fully differentiated state,
yielding data that are more relevant to the investigationOur previous immunohistochemical study of the dia-
of many renal diseases including diabetic nephropathy.betic db/db mouse versus the non-diabetic db/m mouse
Previous studies investigating the effects of high glucoseshowed that the increase in TGF-1 protein was local-
ized to the mesangium and the capillary loops of the and TGF-1 on the glomerular epithelial cell were ham-
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the expression of collagen IV, VEGF, and TRII in the
differentiated mouse podocyte. The stimulatory effects
of high glucose on collagen synthesis were seen in the
increased proline incorporation, in the elevated levels
of 1 and 5(IV) mRNA, and in the increased produc-
tion of 1(IV), 3(IV), and 5(IV) proteins. These find-
ings were not due to an osmotic effect of high glucose
because an equivalent concentration of d-mannitol did
not produce the above results. In many renal cell types,
high glucose stimulates collagen IV production by acti-
vating the cellular TGF- system [12]. Specifically, high
glucose increases the secretion of endogenous TGF-1
that then acts upon the cell in autocrine fashion to stimu-
late the expression of collagen IV and other extracellular
matrix proteins [23]. In the case of the podocyte, how-
ever, high glucose does not increase TGF-1 by either
Northern analysis or ELISA, and high glucose and exog-
enous TGF-1 have disparate effects on the expression
of 1 and 5(IV) collagen. Therefore, despite its ability
to promote matrix production in a wide variety of renal
cells, the TGF- system likely does not mediate all of the
effects of high glucose to stimulate collagen IV expres-
sion in the podocyte. Of course, the 2, 4, and 6 chains
will have to be studied to complete the profile of high
glucose and TGF-1 effects on collagen IV expression.
Besides an absolute increase in collagen IV production
that may alter the quantity of GBM, a relative increase
in one collagen IV alpha chain over another may affect
the ‘quality’ of the GBM. The collagen IV alpha chains
can self-assemble (via molecular recognition sequences
in their NC1 domains) into a triple helical monomer in
one of two ways: as an 1·2·1 network or as an
3·4·5 network [51]. The 3·4·5 network is mostly
found in the subepithelial aspect of the GBM and is
laid down by the overlying podocytes [2]. A relative
deficiency of one of these chains may disrupt the incorpo-Fig. 11. Immunohistochemistry of kidney sections (magnification400)
ration of the other two chains into a collagen IV mono-showing increased type II receptor protein in podocytes in diabetic
db/db mice versus non-diabetic db/m mice. Kidney sections were in- mer [51]. On the other hand, an excess of one chain may
cubated with a rabbit antibody against the TGF- type II receptor competitively inhibit the NC1 interactions and prevent
(TRII). A secondary biotinylated anti-rabbit antibody and then a
the normal assembly of a collagen IV network [51]. Instreptavidin-horseradish peroxidase were subsequently added. The
color reaction was developed with a diaminobenzidine detection kit either case, the high glucose- or TGF-1–induced changes
(Vector Laboratories), and the sections were counterstained with hema- in the expression pattern of the collagen IV alpha chains
toxylin. TRII protein stained more abundantly in the glomeruli of the
may perturb the suprastructure of the GBM and affectdb/db vs. the db/m mouse (A and B). In particular, TRII protein was
increased in the podocytes (arrows) of the db/db mouse (panel B). its function as a filtration barrier.
In addition to structural and compositional changes
in the GBM, the stimulated production of VEGF by the
podocyte may play a role in the pathophysiology of dia-
pered by the tendency of the podocyte to undergo de- betic proteinuria. While the mechanism of proteinuria
differentiation in culture [49]. Moreover, the glomerular is not entirely understood, VEGF may work by causing
epithelial cell may not have been a true podocyte [50]. vasodilation through nitric oxide release [52], by inducing
Preparations of podocytes are often contaminated by endothelial fenestrations [53], and by opening the junc-
glomerular parietal epithelial cells, which line Bowman’s tions between endothelial cells [54]. All of these actions
space and can overgrow the podocytes in culture [36]. would allow more protein to leak across the glomerular
To our knowledge, we show for the first time that ex- endothelium. In health, the podocyte-derived VEGF,
which is constitutively expressed, may travel across theposure to high ambient glucose significantly increases
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GBM and maintain the fenestrations of the glomerular pression of these collagen IV chains via a TGF-–
dependent mechanism.endothelium [35]. How VEGF reaches the endothelial
In another sense, high glucose does activate the TGF-cell against the tide of glomerular filtration is not known,
system in the podocyte, not at the ligand level but atbut we speculate that the heavier VEGF isoforms may
the receptor level. The stimulation of TRII expression,be carried across the GBM. The VEGF164, 188, 205 isoforms
seen in this study, suggests that the readiness of thehave heparin-binding domains that allow them to attach
podocyte to respond to TGF-1 also may underlie someto the side chains of heparan sulfate proteoglycan, an
of the high glucose effects. Given that high glucose in-abundant component of the GBM. The heparan sulfate
creases the abundance of TRII on the podocyte cellside chains, varying in length from 5 to 70 kD, enjoy
surface, we theorized that exogenous TGF-1 wouldample freedom to move laterally, and these linear poly-
have a more pronounced effect in high glucose than inmers can swing around to reach distant targets, as far as
normal glucose. Consistent with this, the addition of aseveral hundreds of nanometers away [55]. Thus, he-
physiological concentration of exogenous TGF-1 to po-paran sulfate could easily cross a full-thickness basement
docytes that had been ‘pre-treated’ with high glucosemembrane [55] and perhaps deliver VEGF from the
resulted in larger absolute increases of 3(IV) collagenpodocyte to the glomerular endothelial cell.
and VEGF proteins than the increases due to either highIn diabetes, an inappropriate rise in VEGF production
glucose or TGF-1 in normal glucose. The interactionby the podocyte may increase the glomerular vascular
between high glucose and TGF-1, however, cannot bepermeability and exacerbate proteinuria. Indeed, histo-
construed as synergistic, but that might be expected,logical evidence suggests that diabetes raises the VEGF
since the TGF- system partly mediates the high glucosegene expression and protein production in the podocyte
effects on 3(IV) collagen and VEGF.[32, 56]. Consistent with this, we found that high glucose
Our data show that high ambient glucose and TGF-1and TGF-1 increase the mRNA and protein levels of
coordinately induce the production of 3(IV) collagenVEGF in the mouse podocyte. In support of a role for
and VEGF in the podocyte. However, high glucose andVEGF in proteinuria, the expression of VEGF and its
TGF-1 exert disparate effects on the expression of 1receptors is increased intrarenally in animal models of
and 5(IV) collagen. This novel finding challenges thediabetes and in diabetic humans [32, 56]. The serum
paradigm that high glucose acts through the TGF- sys-VEGF concentration and urinary VEGF excretion cor-
tem to stimulate collagen IV production in renal cells,relate with the risk for and degree of albuminuria [31,
which include the mesangial [23], glomerular endothelial56, 57]. Finally, treatment with a neutralizing anti-VEGF
[59], and proximal tubular [60] cells. In this respect, theantibody completely corrected the glomerular hyperfil-
podocyte differs from the other renal cell types, but
tration and partially corrected the albuminuria in strep-
the intracellular pathway that mediates the high glucose
tozotocin (STZ)-diabetic rats, providing the strongest effect on 1 and 5(IV) collagen remains unknown. As
evidence to date that VEGF overexpression in the kid- is the case with the mesangial cell [17], high glucose up-
ney contributes to diabetic proteinuria [33]. regulates the expression of the TGF- type II receptor
Because high glucose can modify the response of a in the podocyte, both in cell culture and in the db/db
renal cell to TGF- [17], we examined the effect of high mouse. This phenomenon may allow the podocyte to
glucose on the expression of components of the TGF- react more vigorously to the effects of TGF-1, and it
system. Even though high glucose does not raise the sets up a glomerular paracrine system in which higher
total amount of TGF-1 protein in podocyte cell culture, than normal levels of TGF-1 coming from the mesan-
it may still increase the bioactivity of TGF-1. High gium or glomerular endothelium can affect the neigh-
glucose is known to stimulate the production of throm- boring podocyte. Thus, high glucose may either accentu-
bospondin-1, a secreted matrix protein that binds and ate or antagonize the effects of TGF-1 depending on
converts the latent form of TGF- into the active form the collagen IV or VEGF parameter that is being studied.
[58]. Thus, enough active TGF-1 may accrue in the cell Such changes in the podocyte’s expression of the colla-
environment to mediate an effect of high glucose. In gen IV alpha chains and VEGF isoforms may trigger or
fact, our data show that high glucose acts mostly through worsen the GBM thickening and proteinuria of diabetic
the TGF- system to induce production of 3(IV) colla- glomerulopathy.
gen protein and partially through the TGF- pathway
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